关键词：艾滋病；HIV病毒；自我保护能力；医疗设备
摘 要：AIDS is a life-threatening disease caused by a virus called HIV. In this disease certain white blood cells (lymphocytes) are destroyed, resulting in the loss of the body's ability to protect itself against infections, which are called opportunistic infections. HIV attacks the body's white blood cells, specifically a subset called CD4 or helper T cells. AIDS/HIV testing devices are medical devices that are used to determine the presence of HIV in human blood. There are several testing devices available in the market, including the HIV antibody test, antigen (p24) test, and PCR test. HIV testing is also used to reduce the risk of transmission during blood transfusions and tissue transplantation.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Overview: HIV and AIDS

06.1.1 Types of HIV

07. Market Landscape

07.1 Market Overview

07.2 Market Size and Forecast

07.3 Five Forces Analysis

08. Market Segmentation by Category

08.1 Global HIV-AIDS Testing Market by Category

09. Market Segmentation by Test Type

09.1.1 Antibody Tests

09.1.2 Antigen Tests

09.1.3 PCR Tests

10. Geographical Segmentation

10.1 Global HIV-AIDS Testing Market by

Geographical Segmentation

11. Top 20 Countries with HIV-infected

Population

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

19.1 Competitive Scenario

19.1.1 Key News

19.1.2 Mergers and Acquisitions

19.2 Market Share Analysis 2013

19.3 Other Prominent Vendors

20. Key Vendor Analysis

20.1 Abbott Laboratories Inc.

20.1.1 Key Facts

20.1.2 Business Description

20.1.3 Business Segmentation

20.1.4 Business Strategy

20.1.5 Revenue by Business Segmentation

20.1.6 Revenue Comparison 2011 and 2012

20.1.7 Revenue by Geographical Segmentation

20.1.8 Key Information

20.1.9 SWOT Analysis

20.1.10 Strengths

20.1.11 Weaknesses

20.1.12 Opportunities

20.1.13 Threats

20.2 Bio-Rad Laboratories Inc.

20.2.1 Key Facts

20.2.2 Business Description

20.2.3 Business Segmentation

20.2.4 Business Strategy

20.2.5 Revenue by Business Segmentation

20.2.6 Revenue Comparison 2011 and 2012

20.2.7 Revenue by Geographical Segmentation

20.2.8 Key Information

20.2.9 SWOT Analysis

20.2.10 Strengths

20.2.11 Weaknesses

20.2.12 Opportunities

20.2.13 Threats

20.3 Hologic Inc.

20.3.1 Key Facts

20.3.2 Business Description

20.3.3 Business Segmentation

20.3.4 Business Strategy

20.3.5 Revenue by Business Segmentation

20.3.6 Revenue Comparison 2012 and 2013

20.3.7 Revenue by Geographical Segmentation

20.3.8 Key Information

20.3.9 SWOT Analysis

20.3.10 Strengths

20.3.11 Weaknesses

20.3.12 Opportunities

20.3.13 Threats

20.4 Ortho-Clinical Diagnostics Inc.

20.4.1 Key Facts

20.4.2 Business Overview

20.4.3 Key Information

20.4.4 SWOT Analysis

20.4.5 Strengths

20.4.6 Weaknesses

20.4.7 Opportunities

20.4.8 Threats

20.5 Roche Diagnostics Inc.

20.5.1 Key Facts

20.5.2 Business Description

20.5.3 Business Segmentation

20.5.4 Revenue by Business Segmentation

20.5.5 Revenue by Geographical Segmentation

20.5.6 Business Strategy

20.5.7 Key Information

20.5.8 SWOT Analysis

20.5.9 Strengths

20.5.10 Weaknesses

20.5.11 Opportunities

20.5.12 Threats

20.6 Siemens Healthcare Diagnostics Inc. .

20.6.1 Key Facts

20.6.2 Business Overview

20.6.3 Key Information

20.6.4 Business Strategy

20.6.5 SWOT Analysis

20.6.6 Strengths

20.6.7 Weaknesses

20.6.8 Opportunities

20.6.9 Threats

21. Other Reports in this Series